TNF-Alpha Inhibition for Treatment of Alzheimer's Disease - Contacts and Locations

Home

TNF-Alpha Inhibition for Treatment of Alzheimer's Disease

This study has been completed.

Study NCT00203320. Last updated on April 20, 2006. Information provided by Tobinick, Edward Lewis, M.D.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00203320

Locations


United States, California
	100 UCLA Medical Plaza, Suites 205-210
	Los Angeles, California, United States, 90095

Sponsors and Collaborators

Tobinick, Edward Lewis, M.D.

Investigators


Principal Investigator:	Edward L. Tobinick, M.D.	unaffiliated (Assistant Clinical Professor of Medicine, David Geffen School of Medicine at UCLA)